We would love to hear your thoughts about our site and services, please take our survey here.
Well I expected 5% yesterday and 10% today so I'd settle for 13% today.
Do you not think it odd there isn't a bit more fomo heading into the only event the company has signposted this year?
Besides 15% is what about 37m in market cap, that's pretty small beans next to some big announcments
I can't be the only one thinking that next week is the beginning of our endgame, i'm so very excited about it all. Obviously it might turn out to be a damp squib and i'm surprised we haven't seen more speculators coming in ahead of the undoubted news releases but yeah, officially excited.com
You'd expect a reverse speeding ticket at least from this
I'm not sure the number of trades could warrant calling it a pump haha it's literally just a few of us taking a chance on a decent outcome, as you say a coin flip.
Anyone else optimistic for an early / less delayed readout. I think we could get something fairly soon as I expect the CRO have been quite conservative with the enforced delays.
So many variables attached to this share but if the results replicate the success of the Russian studies it's got real potential to take off as a story of interest type drug. Exciting few weeks ahead for sure.
Looks like Art is doing typical Art things in the background, sorry to anyone involved here
People need to chill out, they've got a cash runway of 15 months so why wouldn't they wait for a better time to raise (if its still required). Very science driven presentation but the revenue potential presented was massive even over a small number of sites and good to see them thinking about add ons and reoccurring revenue maximisation
Just seen the Activ-2 news, loading up before it's widespread and Poly release their midday TR-1
I hadn't been that concerned about it til I read the BBC article this morning
The thing I like best about the announcement is the 'as standard' in terms of our integration into their filters...
This is ideal, it the literally printing money and it's all fully funded, surprised it's at these levels still but not going to complain!
I just bought some more and realised that .24 is actually the buy price so the sea of red being sells isn't actually the case...
So a projected revenue increase of c15x between H1 and H2 and a decent expected carryover to trading year 22. Clearly laid out expected profit margins dependent on revenue streams and a pipeline that excludes stale opportunities. Seems pretty promising to me...
Activ P-3 is an international trial with 100+ sites already online, you would expect 3-4 months max for the required numbers with review points as we go through it
And presumably this means the EUA and Preorder is in the pipeline as well...
brakes coming off now
Another one of these 30-80m orders? Bit of a gap to the other MMs when it finally does move
I'm on sharepad, its 4-1 with only CFEP holding firm at 0.33, the price to buy has steadily risen and theres been about 20m bought in the last half an hour.
I'd be happy with your RNS Parm, i'd offer you the investor relations job straight away :)
Honestly i'm looking to trade this a little today and the L2 looks like it surely must tick up in the next 20-30 mins with some decent buys coming in. Any chance of good news dropping so i can make a packet in the next few hours? #refreshinghonesty
Up 33% now!
It seems certain that this is us and the proximity to their gold sponsorship of the NHS procurement event on Sept 15th, it can't be that much of a coincidence as the timing aligns perfectly for a tested and up and running throughput by then. So much easier just to license the tech and take a cut from every mask.
Also these NHS FFP3 mask contracts are huge, they must be £80m plus per annum and the developments focused on improving wearability and the focus on face fit testing should bode well over competitions like the 3M stapled mask. Could be an exciting month ahead.